Article
The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
Oncogene - 27 Aug 1998
Bai R Y, Jahn T, Schrem S, Munzert G, Weidner K M, Wang J Y, Duyster J
Abstract excerpt
Bcr-Abl is an oncogenic tyrosine kinase expressed in tumor cells of CML and a subset of ALL which in its unregulated and activated state is thought to cause cell transformation and leukemia. Bcr-Abl contains several autophosphorylation sites which serve as potential docking sites for SH2-containing signaling molecules. Mutational analysis has indicated that these autophosphorylation sites play a critical role in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
